Is there still a place for myeloablative regimen to transplant young adults with sickle cell disease?

نویسندگان

  • Mathieu Kuentz
  • Marie Robin
  • Nathalie Dhedin
  • Yosr Hicheri
  • Regis Peffault de Latour
  • Pierre Rohrlich
  • Pierre Bordigoni
  • Bénédicte Bruno
  • Gérard Socié
  • Françoise Bernaudin
چکیده

Acknowledgments: The authors thank Barbara De Moerloose (Ghent, Belgium), Jan Starý (Prague, Czech Republic), Marco Zecca (Pavia, Italy), Franco Locatelli (Rome, Italy), Dorota Wojcik (Wroclaw, Poland), Markus Schmugge (Zurich, Switzerland), Marry M. van den Heuvel-Eibrink (Rotterdam, The Netherlands) and all collaborators of the European Working Group of Myelodysplastic Syndromes in Childhood for contributing clinical data and research material. This work was supported by the Deutsche Forschungsgemeinschaft grant (KR3473/1-1 to C.F.).

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Hematopoietic stem cell transplant therapy, clinical trials, complications, and quality of life for patients with Sickle cell anemia: Clinical potential and future perspectives

Background: Sickle cell anemia (SCA) is an inherited monogenic disorder. The clinical symptoms of SCA are protean, including vaso-occlusion, hemolysis, early stroke, leg ulcers, multi-organ failure, and increased risk of premature death. Hematopoietic stem cell transplantation is the only treatment identified to reduce SCA-related organ damage. Unfortunately, graft rejection is a significant im...

متن کامل

Hematopoietic Stem Cell Transplantation in Adult Sickle Cell Disease: Problems and Solutions

Sickle cell disease-related organ injuries cannot be prevented despite hydroxyurea use, infection prophylaxis, and supportive therapies. As a consequence, disease-related mortality reaches 14% in adolescents and young adults. Hematopoietic stem cell transplantation is a unique curative therapeutic approach for sickle cell disease. Myeloablative allogeneic hematopoietic stem cell transplantation...

متن کامل

Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.

Although sickle cell disease (SCD) has a variable clinical course, many patients develop end-organ complications that are associated with significant morbidity and early mortality. Myeloablative allogeneic HSCT (allo-HSCT) is curative but has been historically performed only in children younger than 16 years of age. Modest modifications in the conditioning regimen and supportive care have impro...

متن کامل

Pattern of chronic lung lesions in adults with sickle cell disease in Lagos, Nigeria

Background: The vascular response to recurrent tissue hypoxia and reperfusion following red blood cell sickling causes acute chest syndrome and chronic lung disease. The purpose of this study was to determine the pattern of chronic lung lesions and possible risk factors in sickle cell patients in lagos, Nigeria.Methods: From July 2012 to April 2013, Pulmonary function test (PFT) and chest-x-ray...

متن کامل

An infant Presenting with Cerebrovascular Accident was Diagnosed as a Sickle Cell Disease Patient: a Case Report

Sickle cell disease (SCD) is a known inherited hemoglobin disorder featured by the presence of sickle shaped erythrocytes in the blood. It can cause cerebrovascular accident (CVA) in adults and children and is responsible for the majority of the strokes in children. Repeated blood transfusion are often required in an attempt to dilute blood thus reducing the risk of vaso-occlusion and stroke in...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Blood

دوره 118 16  شماره 

صفحات  -

تاریخ انتشار 2011